Table 2.
Study events in the study and control groups.
| Event | AMD group | Control group | aHR (95% CI) | ||||
|---|---|---|---|---|---|---|---|
| Person-months | Event | Rate# | Person-months | Event | Rate* | ||
| Any psychological care | 331,912 | 418 | 12.59 (11.44–13.86) | 614,305 | 596 | 9.70 (8.95–10.51) | 1.26* (1.11–1.43) |
| Behavioral therapy | 336,789 | 286 | 8.49 (7.56–9.54) | 621,096 | 376 | 6.05 (5.47–6.70) | 1.37* (1.17–1.60) |
| Sleep or anxiety-related disorders | 339,238 | 201 | 5.92 (5.16–6.80) | 624,832 | 250 | 4.00 (3.53–4.53) | 1.47* (1.22–1.77) |
| MDD | 343,792 | 112 | 3.26 (2.71–3.92) | 629,644 | 144 | 2.29 (1.94–2.69) | 1.40* (1.09–1.79) |
AMD age-related macular degeneration, aHR adjusted hazard ratio adjusted for age, sex, education, marital status, and comorbidities, CI confidential interval, MDD major depression disorder.
*Significant difference.
#Crude incidence rate per 10,000 person months.